These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Epinephrine administration for severe adverse reactions to contrast agents. Samett EJ; Espinosa GA Radiology; 1995 Sep; 196(3):879. PubMed ID: 7644663 [No Abstract] [Full Text] [Related]
25. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA]. Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470 [TBL] [Abstract][Full Text] [Related]
26. Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry. Bruder O; Schneider S; Nothnagel D; Pilz G; Lombardi M; Sinha A; Wagner A; Dill T; Frank H; van Rossum A; Schwitter J; Nagel E; Senges J; Sabin G; Sechtem U; Mahrholdt H JACC Cardiovasc Imaging; 2011 Nov; 4(11):1171-6. PubMed ID: 22093267 [TBL] [Abstract][Full Text] [Related]
27. Fatal reaction to gadopentetate dimeglumine. Jordan RM; Mintz RD AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905 [No Abstract] [Full Text] [Related]
28. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis. Abraham JL; Edward M AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307 [No Abstract] [Full Text] [Related]
29. Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Jung JW; Kang HR; Kim MH; Lee W; Min KU; Han MH; Cho SH Radiology; 2012 Aug; 264(2):414-22. PubMed ID: 22550309 [TBL] [Abstract][Full Text] [Related]
31. Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates. Li A; Wong CS; Wong MK; Lee CM; Au Yeung MC Br J Radiol; 2006 May; 79(941):368-71. PubMed ID: 16632615 [TBL] [Abstract][Full Text] [Related]
32. Alternatives to GBCA: Are We There Yet? Wesolowski JR; Kaiser A Top Magn Reson Imaging; 2016 Aug; 25(4):171-5. PubMed ID: 27367312 [TBL] [Abstract][Full Text] [Related]
33. Anaphylaxis to gadolinium radiocontrast: a case report and review of the literature. Shepherd M; Lata S; Mani S; Fiorillo A; Kumar P J La State Med Soc; 2009; 161(5):282-4. PubMed ID: 19927942 [TBL] [Abstract][Full Text] [Related]
34. Do MRI agents cause or worsen acute pancreatitis? Erenoğlu C; Uluutku AH; Top C; Akin ML; Celenk T Ulus Travma Acil Cerrahi Derg; 2007 Jan; 13(1):78-9. PubMed ID: 17310418 [TBL] [Abstract][Full Text] [Related]
35. Anaphylaxis to amidotrizoate proved by skin testing and flow cytometry-based basophil activation test. Dewachter P; Nicaise-Roland P; Kalaboka S; Lefèvre J; Chollet-Martin S Allergy; 2009 Mar; 64(3):501-2. PubMed ID: 19284406 [No Abstract] [Full Text] [Related]
37. Severe anaphylactoid shock secondary to gadolinium contrast media. Simons CW; Benouni S; Gibbon G; Klaustermeyer W Ann Allergy Asthma Immunol; 2009 Oct; 103(4):359-60. PubMed ID: 19852205 [No Abstract] [Full Text] [Related]
38. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease. Shenoy C Am J Med; 2008 Jan; 121(1):e11; author reply e13. PubMed ID: 18187056 [No Abstract] [Full Text] [Related]
39. Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network. Stratta P; Canavese C; Quaglia M; Fenoglio R Rheumatology (Oxford); 2010 Apr; 49(4):821-3. PubMed ID: 20032228 [No Abstract] [Full Text] [Related]